Showing results (551-560 of 628) with videos related to

Sort By:
Pageof 63
Journal of Lipid Research|April 15, 2014
RNA binding protein HuR regulates the expression of ABCA1Cristina M Ramírez, Chin Sheng Lin, Kotb Abdelmohsen, et al.
Annals of Surgical Oncology|November 9, 2007
Diagnostic accuracy of fine needle biopsy for metastatic melanoma and its implications for patient managementAnna Doubrovsky, Richard A Scolyer, Rajmohan Murali, et al.
Journal of the American College of Cardiology|December 14, 2011
High-sensitivity C-reactive protein is within normal levels at the very onset of first ST-segment elevation acute myocardial infarction in 41% of cases: a multiethnic case-control studyNicole Cristell, Domenico Cianflone, Alessandro Durante, et al.
Plos One|May 11, 2012
GFAP-Cre-mediated transgenic activation of Bmi1 results in pituitary tumorsBart A Westerman, Marleen Blom, Ellen Tanger, et al.
European Heart Journal. Acute Cardiovascular Care|May 17, 2014
Plasma levels of active Von Willebrand factor are increased in patients with first ST-segment elevation myocardial infarction: a multicenter and multiethnic studyB Rutten, A Maseri, D Cianflone, et al.
Environmental Science & Technology|November 23, 2020
Investigation into Adaptation in Genes Associated with Response to Estrogenic Pollution in Populations of Roach (Rutilus rutilus) Living in English RiversPatrick B Hamilton, Anne E Lockyer, Tamsyn M Uren Webster, et al.
Cell Death and Differentiation|April 6, 2024
A novel inhibitory BAK antibody enables assessment of non-activated BAK in cancer cellsHema Preethi Subas Satish, Sweta Iyer, Melissa X Shi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 24, 2013
Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE studyIan Buysschaert, Christophe L Dubois, Joseph Dens, et al.
The American Journal of Pathology|July 30, 2016
Musashi1 Impacts Radio-Resistance in Glioblastoma by Controlling DNA-Protein Kinase Catalytic SubunitPatricia Rosa de Araujo, Aparna Gorthi, Acarizia E da Silva, et al.
Cancer Biology & Therapy|September 3, 2011
VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cellsLymor Ringer, Paul Sirajuddin, Mary Heckler, et al.
Pageof 63